Erna Solberg Global Fund appointment gives Norway’s former prime minister a new international role in global health, as she prepares to chair the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria from 2026 to 2029.
The former Norwegian Prime Minister and Conservative Party (Høyre) figure has been selected as the next Chair of the Board of the Geneva-based partnership, which finances programmes against three of the world’s most persistent infectious diseases. Her mandate will begin in late October and run for three years.
Erna Solberg Global Fund role begins at a difficult moment
The Global Fund said Solberg was chosen together with Javier Hourcade Bellocq, who will serve as Vice-Chair. The two were selected after a competency-based process launched in December 2025 and approved by the Fund’s Board on 2 June 2026.
Solberg said the organisation had shown that multilateral cooperation can save lives, strengthen health systems and build resilience against future threats. She added that, in a period of geopolitical and economic uncertainty, protecting the progress made against HIV, tuberculosis and malaria is “more important than ever”.
The appointment gives Solberg a prominent international platform after a long domestic political career. She served as Norway’s Prime Minister from 2013 to 2021 and led the Conservative Party for more than two decades. In the Storting, the Norwegian Parliament, she remains a senior political figure with extensive foreign policy and international development experience.
Norway links the appointment to global health diplomacy
Norway’s Ministry of Foreign Affairs (Utenriksdepartementet) welcomed the appointment, framing it as recognition of Solberg’s work on global health, vaccine cooperation and sustainable development.
Minister of International Development Åsmund Aukrust (Arbeiderpartiet) said Solberg was “well qualified” for the position, citing her role as prime minister in placing global health and sustainable development high on the international agenda.
During Solberg’s time in office, Norway was involved in the creation of the Coalition for Epidemic Preparedness Innovations (CEPI), an international initiative launched to strengthen preparedness for emerging infectious diseases. Her government also supported Gavi, the Vaccine Alliance, and promoted international coordination on vaccines, diagnostics and treatment during the COVID-19 pandemic.
The Global Fund faces pressure on financing and disease control
The Global Fund to Fight AIDS, Tuberculosis and Malaria is one of the most important multilateral mechanisms in global health. It invests up to about €4.3 billion a year in programmes against HIV, tuberculosis and malaria, while also strengthening health and community systems.
According to the organisation’s 2025 results, programmes supported by the Global Fund partnership have helped save 70 million lives since its creation in 2002. In 2024, 25.6 million people were receiving antiretroviral therapy for HIV in countries where the Fund invests, while 7.4 million people were treated for tuberculosis.
The appointment comes as the global health financing environment has become more constrained. The Fund has warned that declining international funding could put progress against AIDS, tuberculosis and malaria at risk. For Solberg, this means the role will be less ceremonial than strategic: the Board will have to balance limited resources, donor expectations and the needs of countries where disease burdens remain high.
Norway remains a major donor to the Global Fund
Norway has been a long-standing supporter of the Global Fund. For the 2026–2028 period, Oslo has pledged NOK 2 billion, equal to about €185 million. The Global Fund lists Norway as its 11th largest public donor and the most generous donor on a per capita basis.
The Norwegian contribution is part of a wider development policy tradition in which successive governments have used global health as a field for international influence. Solberg’s appointment reinforces that profile, while also placing a former centre-right leader in a role publicly welcomed by the current Labour-led government.
The political significance is therefore broader than Solberg’s personal career. It shows continuity in Norway’s international health policy, even across party lines, and confirms the Nordic country’s preference for multilateral institutions as tools for addressing global risks.
A Nordic role in defending multilateral health cooperation
Solberg’s new position will place her at the centre of debates on how to preserve progress against HIV, tuberculosis and malaria while international cooperation faces pressure from geopolitical tensions, aid cuts and competing budget priorities.
For Norway and the wider Nordic region, the appointment fits a familiar diplomatic pattern: small and medium-sized European countries often seek influence through international institutions, development finance and health cooperation. In this case, the challenge will be to turn political credibility into practical governance at a time when global health systems are being tested by both old diseases and new crises.
The Global Fund’s next phase will depend on whether donors, recipient countries and civil society can maintain a shared strategy. Solberg’s task will be to help hold that coalition together.
